Skip to main content Skip to section navigation Skip to footer
Investor Relations
VIZZ eye drops Back to lenz-tx.com
LENZ Therapeutics, Inc. IR Home
  • Overview
  • News & Events
  • Company Info
  • Financial Results
  • Stock Data
  • SEC Filings
  • Governance
  • VIZZ eye drops
  • Back to lenz-tx.com

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
  • Media
Mar 19, 2025 4:05pm EDT

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 11, 2025 8:00am EDT

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025

Mar 03, 2025 8:00am EST

LENZ Therapeutics to Host Commercial Day on April 15, 2025

Feb 24, 2025 8:00am EST

LENZ Therapeutics to Participate in Upcoming Investor Conferences

Nov 12, 2024 8:00am EST

LENZ Therapeutics to Participate in Upcoming Investor Conferences

Nov 06, 2024 7:00am EST

LENZ Therapeutics Reports Third Quarter 2024 Financial Results

Oct 30, 2024 8:00am EDT

LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024

Oct 27, 2024 9:00pm EDT

CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100

Oct 21, 2024 8:00am EDT

LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia

Sep 30, 2024 8:00am EDT

LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2025 LENZ Therapeutics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences